comparemela.com

Latest Breaking News On - Genocea biosciences company profile - Page 1 : comparemela.com

Genocea Biosciences (NASDAQ:GNCA) Research Coverage Started at StockNews com

StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report released on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a debt-to-equity ratio of 0.24, a current ratio of 1.35 and a quick ratio of 1.35. Genocea Biosciences has […]

Genocea Biosciences (NASDAQ:GNCA) Coverage Initiated at StockNews com

StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of […]

Genocea Biosciences (NASDAQ:GNCA) Coverage Initiated at StockNews com

Equities research analysts at StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a report issued on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a market cap of $6,000.00, a price-to-earnings ratio of 0.00 and a beta of […]

StockNews com Initiates Coverage on Genocea Biosciences (NASDAQ:GNCA)

StockNews com Initiates Coverage on Genocea Biosciences (NASDAQ:GNCA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

StockNews com Begins Coverage on Genocea Biosciences (NASDAQ:GNCA)

StockNews.com initiated coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report released on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.24. Genocea Biosciences […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.